A carregar...

CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery

Advances in translational research are often driven by new technologies. The advent of microarrays, next-generation sequencing, proteomics and RNA interference (RNAi) have led to breakthroughs in our understanding of the mechanisms of cancer and the discovery of new cancer drug targets. The discover...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trends Cancer
Autor principal: Luo, Ji
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5461962/
https://ncbi.nlm.nih.gov/pubmed/28603775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2016.05.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!